Trysignalbase

eRAD has closed a $22.0 million Series A round, the US-based medical imaging workflow company announced on September 28, 2026. The raise was led by Middle East Venture Partners (MEVP) and includes a broad syndicate of regional and global backers — among them 500 Global, SVC, S60 Ventures, anb capital, Conjunction Capital, Arāya Ventures, Nuwa Capital, Khawarizmi Ventures, AlJazira Capital (الجزيرة كابيتال), Oraseya Capital and Joā Capital. Founded in 1999 and headquartered in the United States, eRAD employs roughly 71 people and reports more than 400 customers across the US and several other countries.

"Big day for erad: $22M Series A, led by Middle East Venture Partners (MEVP). This raise fuels what's next: more sectors, more products, more scale, faster. Thank you to our new investors Middle East Venture Partners (MEVP), 500 Global, SVC, S60 Ventures, anb capital, Conjunction Capital, and Arāya Ventures for joining, and to Nuwa Capital, Khawarizmi Ventures, AlJazira Capital الجزيرة كابيتال, Oraseya Capital and Joa Capital for doubling down. Onward." — Youssef

The funding will underpin eRAD's expansion of its imaging workflow portfolio, which includes radiology information systems (RIS), web-based picture archiving and communication systems (PACS), and multi-site workflow tools. These products are targeted at teleradiology businesses, specialty reading groups, hospitals and outpatient imaging centers. eRAD offers its software as cloud-hosted solutions as well as in-house enterprise deployments, a flexibility that has helped it secure its installed base of more than 400 customers.

Company materials list the newly raised $22.0 million as eRAD's total funding at Series A and point to a strategy of broadening product scope and scaling operations. The investor mix — spanning regional specialist funds such as MEVP and Khawarizmi Ventures, established global seed-to-growth backers like 500 Global, and a number of Middle East-focused capital firms including AlJazira Capital and Oraseya Capital — signals interest in both the company's technology and its potential to serve cross-border imaging networks.

Investor lineup and strategic implications

• Lead investor: Middle East Venture Partners (MEVP)
• Participants: 500 Global, SVC, S60 Ventures, anb capital, Conjunction Capital, Arāya Ventures
• Existing investors who increased exposure: Nuwa Capital, Khawarizmi Ventures, AlJazira Capital (الجزيرة كابيتال), Oraseya Capital, Joā Capital

Industry insiders say radiology remains a high-priority vertical for digital transformation, driven by demand for distributed reading models and cloud-native image management. eRAD's combination of RIS, PACS and multi-site workflow tooling places it in a competitive set of vendors that aim to streamline reading pipelines and support remote, multi-subscriber interpretation models. eRAD's product flexibility — available as cloud-hosted or on-premise — is likely to be a selling point for hospitals balancing security, integration and scalability concerns.

Looking ahead, the company has signalled it will use the Series A to accelerate product development and market expansion across additional sectors and geographies. With a well-capitalised syndicate behind it, eRAD faces the immediate task of converting the investment into measurable growth: adding customers beyond its 400+ base, expanding adoption among large hospital systems and teleradiology groups, and demonstrating differentiated outcomes from its RIS/PACS and workflow offerings. The firm's website is listed as erad.com for additional corporate information.